**More fat is better**

Overweight individuals who switch to a low-fat diet are not as healthy as people who choose a moderate-fat diet, according to research published in the February issue of the *American Journal of Clinical Nutrition*. Investigators from the University of Buffalo designed a dietary intervention trial involving two groups of overweight individuals. The groups were assigned to eat meals containing the same number of calories, but with different proportions of fat. Even though all participants lost the same amount of weight, after 6 weeks those on the moderate-fat diet had a healthier heart profile than those on the low-fat diet.

**Tumour-killing virus**

Researchers at New York University School of Medicine have found a mosquito-borne virus that automatically targets and kills tumour cells, while leaving healthy cells alone. According to a study published in the January issue of *Nature Biotechnology*, unlike other oncolytic viruses the Sindbis virus does not need to be genetically manipulated to be effective, and does not have to be injected directly into the tumour. The researchers found that Sindbis killed tumours in mice at several locations including skin, pancreas, and lungs. Clinical trials of the virus are expected to begin within 2 years.

**Eye problems disrupt sleep**

Damage to the optic nerve can cause sleep disorders by disrupting circadian rhythms, according to research published in the February issue of *Ophthalmology*. Investigators from Washington University Medical School observed the sleep-wakefulness cycles of 25 visually impaired individuals and compared them with the cycles of 12 people with normal sight. They found that people with optic-nerve disease were 20 times more likely to have severe daytime sleepiness. Recalling previous animal studies that identified non-visual photoreceptors on the retina that can communicate directly with the suprachiasmatic nucleus, the authors suggest that people with damaged optic nerves might have difficulty synchronising internal rhythms.

**Ramón wins court case**

Juan Ramón Laporte, editor of the Spanish pharmaceutical publication *Bulletin Groc*, was cleared on Jan 28 of allegations that an article he published was untrue. Pharmaceutical company Merck, Sharpe, and Dohme decided to sue Laporte over a story describing "irregularities" surrounding clinical trials of the company\'s selective COX-2 inhibitor rofecoxib (see *Lancet* 2004; **363**: 298). Rejecting MSD\'s claims, the District Court of Madrid absolved Ramón and ordered the company to pay the trial costs.

**No change in Helsinki**

The World Medical Association have recommended no change to a controversial section of the Declaration of Helsinki that seeks to protect the continuing health care of patients who have been involved in research studies. The decision comes after 2 years of deliberation by the WMA over whether or not it should respond to criticisms of the section. The paragraph under debate states that every patient has a right to the "best proven prophylactic, diagnostic, and therapeutical methods identified by the study", after the trial has ended.

**T cells in pregnancy**

Pregnant mothers do not reject their babies as foreign bodies because regulatory T cells help to suppress immune responses in the womb, according to British researchers. The findings, published online in *Nature Immunology (*doi:10.1038/ni1037), show that when the number of regulatory T cells is reduced experimentally in mice, fetuses are rejected. The authors suggest that increasing the number of regulatory T cells might help prevent premature abortion syndromes and pre-eclampsia, and may also lead to new treatments for autoimmune disease and transplant rejection.

**Lingering bacteria**

Bacteria that cause a lethal form of food poisoning can lurk in the gall bladders of seemingly healthy people, according to research published in the Feb 6 issue of *Science*. Investigators from Stanford University School of Medicine tagged *Listeria monocytogenes* bacteria with a luminescent molecule and used whole-body imaging to track the path of infection in mice. Surprisingly, they found that bacteria could proliferate in the gall bladder without causing disease symptoms. To explain their findings, the researchers speculate that the gall bladder provides a safe haven from immune cells and antibiotics.

**Antibody to SARS**

Scientists at the Dana-Faber Cancer Institute in Boston have identifed a human monoclonal antibody that inhibits the SARS coronavirus (*Proc Natl Acad Sci USA*, published online Feb 2, doi:10.1073/pnas.0307140101). The researchers created the antibody after isolating a single-chain fragment that was able to bind specifically to the area of the virus that controls fusion with host cells from a library of human antibodies. By blocking membrane fusion, the antibody also prevented syncytia formation. Encouragingly, genome studies indicate that the antibody\'s efficacy is unlikely to be affected by antigen drift over time.

**Victory for free speech**

A Guatemalan tribunal has cleared Bruce Harris---a regional director for Casa Alianza, an organisation dedicated to the protection of central American street children---of defamation, calumny, and slander. The charges were brought against him by the ex-wife of the former president of Guatemala who was named on a list, put together by Casa Alianza, of people involved in "irregularities" to do with international adoptions of Guatemalan children. The ruling is seen as a victory by those campaigning for freedom of expression in Guatemala; since 1999, the right to free speech has been restricted to journalists.
